Friday, March 30, 2018
MarcasUSA, LLC Emite Retiro Voluntariamente a Nivel Nacional de Pasta De Lassar Andromaco Protector de la Piel con 25% de óxido de Zinc, en Tubos de 60 Gramos, Debido a Contaminación Microbiana - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2GXWZeO
via IFTTT
MarcasUSA, LLC Issues Voluntary Nationwide Recall of Pasta De Lassar Andromaco Skin Protectant 25% Zinc Oxide 60g Due to Potential Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2GlnLRc
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the patient perspective and experience in drug development and review - FDA Press Releases
from Food and Drug Administration--Press Releases https://ift.tt/2Grks7a
via IFTTT
Thursday, March 29, 2018
Health Nut Factory Recalls Organic Coconut Smiles Because Of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2IejD1L
via IFTTT
Target Corporation Issues a Voluntary Recall For a Variety of Frozen Products Sold at a Single Store on Oahu - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://bit.ly/2pQeoxL
via IFTTT
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse - FDA Press Releases
from Food and Drug Administration--Press Releases https://ift.tt/2GS9kRv
via IFTTT
Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA - FDA Press Releases
from Food and Drug Administration--Press Releases https://ift.tt/2J2ixaC
via IFTTT
Wednesday, March 28, 2018
Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs - FDA Press Releases
from Food and Drug Administration--Press Releases https://ift.tt/2J1Ipng
via IFTTT
Tuesday, March 27, 2018
First Source Issues Allergy Alert on Undeclared Peanuts in Wegmans 9 Oz Yogurt Raisins - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2I7yYRI
via IFTTT
FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices - FDA Press Releases
from Food and Drug Administration--Press Releases https://ift.tt/2GcaeLD
via IFTTT
eBars Issues Allergy Alert on Undeclared Allergens - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2pL5v8H
via IFTTT
Monday, March 26, 2018
Darwin’s Natural Pet Products Issues Voluntary Recalls for Darwin’s Brand Dog Foods Due To Contamination Salmonella And Shiga Toxin-Producing Escherichia Coli O128 - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2ur0oQO
via IFTTT
Allergy Alert Issued in Select Northern California Whole Foods Market Stores for Undeclared Egg in Some Cookies - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2upqRxY
via IFTTT
Correction to: Halistanol sulfates I and J, new SIRT1–3 inhibitory steroid sulfates from a marine sponge of the genus Halichondria - Journal of Antibiotics
Correction to: Halistanol sulfates I and J, new SIRT1–3 inhibitory steroid sulfates from a marine sponge of the genus Halichondria
Correction to: Halistanol sulfates I and J, new SIRT1–3 inhibitory steroid sulfates from a marine sponge of the genus <i>Halichondria</i>, Published online: 27 March 2018; doi:10.1038/s41429-017-0019-6
Correction to: Halistanol sulfates I and J, new SIRT1–3 inhibitory steroid sulfates from a marine sponge of the genus Halichondriafrom The Journal of Antibiotics - Issue - nature.com science feeds https://ift.tt/2unuBQw
via IFTTT
Blue Ridge Beef Voluntarily Recalls BRB Complete Raw Pet Food Lot#GA0131 Because of Possible Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2IRbOQO
via IFTTT
Mrs. Gerry’s Kitchen Issues Allergen Alert on Undeclared Seafood in Salad - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2pIbz1O
via IFTTT
Kwik Trip, Inc. Issues Allergen Alert for Undeclared Fish or Shellfish on Premium Egg Salad Sandwich on Oat Multigrain Bread - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2IRKO3P
via IFTTT
Saturday, March 24, 2018
Tamarack Inc. Recalls Eclipse Kratom Because of Possible Salmonella Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2pEanMV
via IFTTT
Friday, March 23, 2018
Poppies International, Inc. Recalls Delizza Belgian Custard Cream Mini Eclairs 30 Count, Due to Potential Health Risks - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2GlcIGK
via IFTTT
King Arthur Flour Company, Inc. Voluntarily Recalls Organic Coconut Flour (16 Oz.) Because of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2G5Ug1A
via IFTTT
Limited Production of Two Varieties of Milo’s Kitchen® Dog Treats Voluntarily Recalled Due to Potentially Elevated Levels of Thyroid Hormone - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2DPbxKr
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2GgIeG6
via IFTTT
Thursday, March 22, 2018
BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2pyefyY
via IFTTT
Statement from FDA’s Donald St. Pierre on findings from ongoing investigation into lead testing issues - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2pxB8n3
via IFTTT
Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp. - Journal of Antibiotics
Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.
Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from <i>Streptomyces</i> sp., Published online: 22 March 2018; doi:10.1038/s41429-018-0044-0
Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2FTRmB9
via IFTTT
Tolyprolinol, a new dipeptide from Tolypocladium sp. FKI-7981 - Journal of Antibiotics
Tolyprolinol, a new dipeptide from Tolypocladium sp. FKI-7981
Tolyprolinol, a new dipeptide from <i>Tolypocladium</i> sp. FKI-7981, Published online: 22 March 2018; doi:10.1038/s41429-018-0041-3
Tolyprolinol, a new dipeptide from Tolypocladium sp. FKI-7981from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2puGKh1
via IFTTT
Wednesday, March 21, 2018
Weis Markets Issues an Allergy Alert For Weis Quality Store-Made Cole Slaw Sold in 8 Stores Due to Undeclared Egg Allergen - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2GfB0lE
via IFTTT
Tuesday, March 20, 2018
Piggie Park Enterprises Inc. Issues Allergy Alert on Undeclared Wheat and Soy in Maurice's Southern Gold Honey Sauce - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2GcFF7N
via IFTTT
Piggie Park Enterprises Inc. Issues Allergy Alert on Undeclared Wheat and Soy in Gourmet Carolina Gold Honey Sauce - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FQeyQq
via IFTTT
Radagast Pet Food, Inc. Voluntarily Recalls One Lot of Rad Cat Raw Diet Free-Range Chicken and One Lot of Free-Range Turkey Recipe Because of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FWl83W
via IFTTT
FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2puKE9p
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2u56CFM
via IFTTT
Monday, March 19, 2018
Vietti Foods Issues Allergy Alert on Undeclared Wheat and Eggs in Southgate Hot Dog Chili Sauce - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FM72WW
via IFTTT
Twelve Haggen Stores Voluntarily Recall Select Deli Products in Cooperation with Taylor Farms’ Onion Recall Due to Possible Salmonella Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2G8QmIA
via IFTTT
Natural Grocers Issues Recall on Coconut Smiles Organic Due to Salmonella - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2HMnvXw
via IFTTT
Confirmation of the absolute configuration of Stachybotrin C using single-crystal X-ray diffraction analysis of its 4-bromobenzyl ether derivative - Journal of Antibiotics
Confirmation of the absolute configuration of Stachybotrin C using single-crystal X-ray diffraction analysis of its 4-bromobenzyl ether derivative
Confirmation of the absolute configuration of Stachybotrin C using single-crystal X-ray diffraction analysis of its 4-bromobenzyl ether derivative, Published online: 19 March 2018; doi:10.1038/s41429-018-0042-2
Confirmation of the absolute configuration of Stachybotrin C using single-crystal X-ray diffraction analysis of its 4-bromobenzyl ether derivativefrom The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2ppzZwS
via IFTTT
Sunday, March 18, 2018
Oregon Food Bank Voluntarily Recalls Nutritional Yeast - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2HL9b1z
via IFTTT
Oregon Food Bank Voluntarily Recalls Pumpkin Seeds Because Of Possible Contamination By Listeria Species - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2G00VxD
via IFTTT
Saturday, March 17, 2018
International Harvest, Inc. Recalls Organic Go Smile! Raw Coconut Because of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2GCvKWY
via IFTTT
PDX Aromatics Expands Recall of Kratom Products Because of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Gzb16h
via IFTTT
Friday, March 16, 2018
River Valley Sprouts Recalls Alfalfa Sprouts and Garlic Alfalfa Sprouts Due to Possible Salmonella Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2pjEE3q
via IFTTT
Chris’s Cookies Recalls Chocolate Chip Cookies Due to Undeclared Peanuts - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FGEyxL
via IFTTT
Bayer Issues Voluntary Recall of Alka-Seltzer Plus® Products - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2DyeBdP
via IFTTT
Thursday, March 15, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2HCb94q
via IFTTT
Wednesday, March 14, 2018
Prognosis After Emergency Department Intubation to Inform Shared Decision-Making - American Geriatric Society
Objectives
To inform the shared decision-making process between clinicians and older adults and their surrogates regarding emergency intubation.
Design
Retrospective cohort study.
Setting
Multicenter, emergency department (ED)-based cohort.
Participants
Adults aged 65 and older intubated in the ED from 2008 to 2015 from 262 hospitals across the United States (>95% of U.S. nonprofit academic medical centers).
Measurements
Our primary outcome was age-specific in-hospital mortality. Secondary outcomes were age-specific odds of death after adjusting for race, comorbid conditions, admission diagnosis, hospital disposition, and geographic region.
Results
We identified 41,463 ED intubation encounters and included 35,036 in the final analysis. Sixty-four percent were in non-Hispanic whites and 54% in women. Overall in-hospital mortality was 33% (95% confidence interval (CI)=34–35%). Twenty-four percent (95% CI=24–25%) of subjects were discharged to home, and 41% (95% CI=40–42%) were discharged to a location other than home. Mortality was 29% (95% CI=28–29%) for individuals aged 65 to 74, 34% (95% CI=33–35%) for those aged 75 to 79, 40% (95% CI=39–41%) for those aged 80 to 84, 43% (95% CI=41–44%) for those aged 85 to 89, and 50% (95% CI=48–51%) for those aged 90 and older.
Conclusion
After emergency intubation, 33% percent of older adults die during the index hospitalization. Only 24% of survivors are discharged to home. Simple, graphic representations of this information, in combination with an experienced clinician's overall clinical assessment, will support shared decision-making regarding unplanned intubation.
from Journal of the American Geriatrics Society http://ift.tt/2pcYWfD
via IFTTT
Improving Care Using a Bidirectional Geriatric Cardiology Consultative Conference - American Geriatric Society
More than 13 million persons in the United States aged 65 and older have cardiovascular disease (CVD), and this population is expected to increase exponentially over the next several decades. In the absence of clinical studies that would inform how best to manage this population, there is an urgent need for collaborative, thoughtful approaches to their care. Although cardiologists are traditionally regarded as leaders in the care of older adults with CVD, these individuals have multiple comorbidities, physiological differences, and distinct goals of care than younger patients that require a specialized geriatric lens. Thus, collaboration is needed between geriatricians, cardiologists, and other specialists to address the unique needs of this growing population. Accordingly, clinicians at New York University Langone Health and School of Medicine established a monthly Geriatric Cardiology Conference to foster an integrative approach to the care of older adults with CVD by uniting specialists across disciplines to collaborate on treatment strategies. At each conference, an active case is discussed and analyzed in detail, and a consensus is reached among participants regarding optimal treatment strategies. The conference attracts faculty and trainees at multiple levels from geriatrics, cardiology, and cardiothoracic surgery. The model may serve as a paradigm for other institutions moving towards geriatric-informed care of older adults with CVD.
from Journal of the American Geriatrics Society http://ift.tt/2HzxwXZ
via IFTTT
Association Between Neighborhood Cohesion and Self-Neglect: Exploring Mental Health in Asian Americans - American Geriatric Society
Reply to: Association between Neighborhood Cohesion and Self-Neglect: Exploring Mental Health in Asian Americans - American Geriatric Society
Spiciferone analogs from an endophytic fungus Phoma betae collected from desert plants in West China - Journal of Antibiotics
Spiciferone analogs from an endophytic fungus Phoma betae collected from desert plants in West China
Spiciferone analogs from an endophytic fungus <i>Phoma betae</i> collected from desert plants in West China, Published online: 14 March 2018; doi:10.1038/s41429-018-0037-z
Spiciferone analogs from an endophytic fungus Phoma betae collected from desert plants in West Chinafrom The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2Io8fBm
via IFTTT
Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of Umezawaea sp. and mycolic acid-containing bacterium - Journal of Antibiotics
Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of Umezawaea sp. and mycolic acid-containing bacterium
Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of <i>Umezawaea</i> sp. and mycolic acid-containing bacterium, Published online: 14 March 2018; doi:10.1038/s41429-018-0040-4
Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of Umezawaea sp. and mycolic acid-containing bacteriumfrom The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2IoB1lt
via IFTTT
Tuesday, March 13, 2018
Health-Related Quality of Life in a Predictive Model for Mortality in Older Breast Cancer Survivors - American Geriatric Society
Objectives
To develop a predictive model and risk score for 10-year mortality using health-related quality of life (HRQOL) in a cohort of older women with early-stage breast cancer.
Design
Prospective cohort.
Setting
Community.
Participants
U.S. women aged 65 and older diagnosed with Stage I to IIIA primary breast cancer (N=660).
Measurements
We used medical variables (age, comorbidity), HRQOL measures (10-item Physical Function Index and 5-item Mental Health Index from the Medical Outcomes Study (MOS) 36-item Short-Form Survey; 8-item Modified MOS Social Support Survey), and breast cancer variables (stage, surgery, chemotherapy, endocrine therapy) to develop a 10-year mortality risk score using penalized logistic regression models. We assessed model discriminative performance using the area under the receiver operating characteristic curve (AUC), calibration performance using the Hosmer-Lemeshow test, and overall model performance using Nagelkerke R2 (NR).
Results
Compared to a model including only age, comorbidity, and cancer stage and treatment variables, adding HRQOL variables improved discrimination (AUC 0.742 from 0.715) and overall performance (NR 0.221 from 0.190) with good calibration (p=0.96 from HL test).
Conclusion
In a cohort of older women with early-stage breast cancer, HRQOL measures predict 10-year mortality independently of traditional breast cancer prognostic variables. These findings suggest that interventions aimed at improving physical function, mental health, and social support might improve both HRQOL and survival.
from Journal of the American Geriatrics Society http://ift.tt/2Gn9Gzr
via IFTTT
Monday, March 12, 2018
Schwartz Brothers Bakery Issues Allergy Alert on Undeclared Egg in Gourmet Cream Cheese Cinnamon Rolls - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2p4Hh9L
via IFTTT
Wegmans Food Markets Issues Allergen Alert on Undeclared Egg in Wegmans Thai Sweet Chili Sauce Cup 1.5 oz. Sold in the Sushi Department - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2tEgnup
via IFTTT
Consumer Alert: Listeria Contamination In Maiden’s Creamery Wild Meadow Raw Goat Milk Cheese - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2ImpuTQ
via IFTTT
Expanding Home-Based Primary Care to American Indian Reservations and Other Rural Communities: An Observational Study - American Geriatric Society
Background/Objectives
Home-based primary care (HBPC) is a comprehensive, interdisciplinary program to meet the medical needs of community-dwelling populations needing long-term care (LTC). The U.S. Department of Veterans Affairs (VA) expanded its HBPC program to underserved rural communities, including American Indian reservations, providing a “natural laboratory” to study change in access to VA LTC benefits and utilization outcomes for rural populations that typically face challenges in accessing LTC medical support.
Design
Pretest-Posttest quasi-experimental approach with interrupted time-series design using linked VA, Medicare, and Indian Health Service (IHS) records.
Setting
American Indian reservations and non-Indian communities in rural HBPC catchment areas.
Participants
376 veterans (88 IHS beneficiaries, 288 non-IHS beneficiaries) with a HBPC length of stay of 12 months or longer.
Measurements
Baseline demographic and health characteristics, activities of daily living (ADL), previous VA enrollment, and hospital admissions and emergency department (ED) visits as a function of time, accounting for IHS beneficiary and functional statuses.
Results
For HBPC users, VA enrollment increased by 22%. At baseline, 30% of IHS and non-IHS beneficiaries had 2 or more ADLs impairments; IHS populations were younger (P < .001) and had more diagnosed chronic diseases (P = .007). Overall, hospital admissions decreased by 0.10 (95% confidence interval (CI) = −0.14 to −0.05) and ED visits decreased by 0.13 (95% CI = −0.19 to −0.07) in the 90 days after HBPC admission (Ps < .001) and these decreases were maintained over 1 year follow-up. Before HBPC, probability of hospital admission was 12% lower for IHS than non-IHS beneficiaries (P = .02).
Conclusion
Introducing HBPC to rural areas increased access to LTC and enrollment for healthcare benefits, with equitable outcomes in IHS and non-IHS populations.
from Journal of the American Geriatrics Society http://ift.tt/2FHLlGL
via IFTTT
Effects of Caps on Cost Sharing for Skilled Nursing Facility Services in Medicare Advantage Plans - American Geriatric Society
Objectives
To evaluate a federal regulation effective in 2011 that limited how much that Medicare Advantage (MA) plans could charge for the first 20 days of care in a skilled nursing facility (SNF).
Design
Difference-in-differences retrospective analysis comparing SNF utilization trends from 2008–2012.
Setting
Select MA plans.
Participants
Members of 27 plans with mandatory cost sharing reductions (n=132,000) and members of 21 plans without such reductions (n=138,846).
Measurements
Mean monthly number of SNF admissions and days per 1,000 members; annual proportion of MA enrollees exiting the plan.
Results
In plans with mandated cost sharing reductions, cost sharing for the first 20 days of SNF care decreased from an average of $2,039 in 2010 to $992 in 2011. In adjusted analyses, plans with mandated cost-sharing reductions averaged 158.1 SNF days (95% confidence interval (CI)=153.2–163.1 days) per 1,000 members per month before the cost sharing cap. This measure increased by 14.3 days (95% CI=3.8–24.8 days, p=0.009) in the 2 years after cap implementation. However, increases in SNF utilization did not significantly differ between plans with and without mandated cost-sharing reductions (adjusted between-group difference: 7.1 days per 1,000 members, 95% CI=–6.5–20.8, p=.30). Disenrollment patterns did not change after the cap took effect.
Conclusions
When a federal regulation designed to protect MA members from high out-of-pocket costs for postacute care took effect, the use of SNF services did not change.
from Journal of the American Geriatrics Society http://ift.tt/2HoSxVu
via IFTTT
Sunday, March 11, 2018
Midwest Northern Nut Issues Voluntary Allergy Alert On Various Undeclared Allergens In Their Nut And Seed Snack Products - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FHqbIB
via IFTTT
Saturday, March 10, 2018
PDX Aromatics Recalls Kratom Powder Because Of Possible Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2DgjN67
via IFTTT
Friday, March 9, 2018
Starwest Botanicals Inc. Product Recalls Organic Cardamom Pods Green (Whole) Due to Possible Salmonella Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Fo2TIy
via IFTTT
FDA warns duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to assess contamination risk - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2FrDuxG
via IFTTT
Diabetes, Heart Disease, and Dementia: National Estimates of Functional Disability Trajectories - American Geriatric Society
Objectives
To estimate the associations between diabetes, heart disease, and dementia, which may increase the difficulty of self-care; model functional disability trajectories jointly with attrition (death or dropout) over 5 years.
Design
Population-based complex survey design.
Setting
National Health and Aging Trends Study.
Participants
Community-dwelling Medicare beneficiaries aged 65 and older (N=7,609).
Measurements
National estimates were generated using sampling weights. Sociodemographic characteristics, self-reported physician-diagnosed chronic conditions, six activities of daily living (ADL), and cognitive status were ascertained in annual in-person interviews. A joint model using group-based trajectory modeling was used to estimate the number of ADL disabilities and attrition probability. Multinomial logistic regression with survey weights was used to estimate the association between diabetes, heart disease, and dementia and resultant trajectories of disability, with the least disabled trajectory used as a reference.
Results
Three functional disability trajectories were identified: 26.9 million (76.3%) individuals with no disability and a constant study attrition of 14.3%, 4.9 million (13.9%) with mild and increasing disability and 12% attrition in 2012 and 27.2% in 2015, and 3.4 million (9.7%) with severe and increasing disability and 25.4% attrition in 2012 and 35% in 2015. Persons with possible dementia, possible dementia and diabetes, or possible dementia with diabetes and heart disease had significantly greater odds of being on the mild disability trajectory than those with no disability. Persons with probable dementia, representing more than 1.5 million persons, regardless of concurrent conditions, had significantly greater odds of being on the severe disability trajectory than on the no disability trajectory.
Conclusions
Methods that generate national estimates and account for attrition and for multiple chronic conditions and cognitive status may be useful for health policy-makers to make decisions on care provisions and services.
from Journal of the American Geriatrics Society http://ift.tt/2Ih4g9F
via IFTTT
Thursday, March 8, 2018
Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations hearing “Examining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza.” - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2FpsQYg
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on effort to help bolster U.S. shellfish market by taking mutually beneficial steps to resume shellfish trade with the EU - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2DbEmAi
via IFTTT
Redbarn Pet Products Expands Voluntary Recall of Dog Chews - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2DamW7d
via IFTTT
Wednesday, March 7, 2018
Ciolo Foods Issues Allergy Alert for Undeclared Tree Nuts in “Ciolo Nut-Free Basil - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Fo0cTa
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA activities related to the ongoing post-market review of Essure and FDA’s commitment to keep women informed - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2G7U6rv
via IFTTT
Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation - Journal of Antibiotics
Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiation
<i>Streptosporangium minutum</i> sp. nov., isolated from garden soil exposed to microwave radiation, Published online: 07 March 2018; doi:10.1038/s41429-018-0036-0
Streptosporangium minutum sp. nov., isolated from garden soil exposed to microwave radiationfrom The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2IcqUQI
via IFTTT
Structure and biosynthesis of mayamycin B, a new polyketide with antibacterial activity from Streptomyces sp. 120454 - Journal of Antibiotics
Structure and biosynthesis of mayamycin B, a new polyketide with antibacterial activity from Streptomyces sp. 120454
Structure and biosynthesis of mayamycin B, a new polyketide with antibacterial activity from <i>Streptomyces</i> sp. 120454, Published online: 07 March 2018; doi:10.1038/s41429-018-0039-x
Structure and biosynthesis of mayamycin B, a new polyketide with antibacterial activity from Streptomyces sp. 120454from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2oWTSLh
via IFTTT
Computational study on formation of 15-membered azalactone by double reductive amination using molecular mechanics and density functional theory calculations - Journal of Antibiotics
Computational study on formation of 15-membered azalactone by double reductive amination using molecular mechanics and density functional theory calculations
Computational study on formation of 15-membered azalactone by double reductive amination using molecular mechanics and density functional theory calculations, Published online: 07 March 2018; doi:10.1038/s41429-018-0030-6
Computational study on formation of 15-membered azalactone by double reductive amination using molecular mechanics and density functional theory calculationsfrom The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2I9Sqy5
via IFTTT
Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from Lechevalieria aerocolonigenes K10-0216 - Journal of Antibiotics
Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from Lechevalieria aerocolonigenes K10-0216
Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from <i>Lechevalieria aerocolonigenes</i> K10-0216, Published online: 07 March 2018; doi:10.1038/s41429-018-0038-y
Pyrizomicin A and B: structure and bioactivity of new thiazolyl pyridines from Lechevalieria aerocolonigenes K10-0216from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2oVkIDR
via IFTTT
Barriers to Implementation of Geriatric Medicine Programs: When Advocacy Meets Reality - American Geriatric Society
This editorial comments on the article by Boustani et al.
from Journal of the American Geriatrics Society http://ift.tt/2I8Vv1p
via IFTTT
Agile Implementation: A Blueprint for Implementing Evidence-Based Healthcare Solutions - American Geriatric Society
Objectives
To describe the essential components of an Agile Implementation (AI) process, which rapidly and effectively implements evidence-based healthcare solutions, and present a case study demonstrating its utility.
Design
Case demonstration study.
Setting
Integrated, safety net healthcare delivery system in Indianapolis.
Participants
Interdisciplinary team of clinicians and administrators.
Measurements
Reduction in dementia symptoms and caregiver burden; inpatient and outpatient care expenditures.
Results
Implementation scientists were able to implement a collaborative care model for dementia care and sustain it for more than 9 years. The model was implemented and sustained by using the elements of the AI process: proactive surveillance and confirmation of clinical opportunities, selection of the right evidence-based healthcare solution, localization (i.e., tailoring to the local environment) of the selected solution, development of an evaluation plan and performance feedback loop, development of a minimally standardized operation manual, and updating such manual annually.
Conclusion
The AI process provides an effective model to implement and sustain evidence-based healthcare solutions.
from Journal of the American Geriatrics Society http://ift.tt/2oYqjZV
via IFTTT
Tuesday, March 6, 2018
Weis Markets Expands Allergy Alert for Weis Quality Dried Beef Party Rye Dip Sold in 11 Stores Due to Undeclared Milk and Egg Allergen - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2oVMpw5
via IFTTT
FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2tjGPt5
via IFTTT
Raw Basics, LLC. Recalls Tucker’s 5lb Pork-Bison Box Because of Possible Salmonella Health Risk - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FgHlgL
via IFTTT
FDA expands approval of replacement heart valve, smallest mechanical valve size approved in the world - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2HbwnG9
via IFTTT
FDA approves new HIV treatment for patients who have limited treatment options - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2Fwq6rd
via IFTTT
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Hcp4hj
via IFTTT
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2D56J3a
via IFTTT
Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice - American Geriatric Society
Objectives
To describe medications that older hospice beneficiaries receive through Medicare Part D and assess patterns in Part D use for individuals admitted to hospice for cancer and noncancer causes.
Design
Descriptive cohort analysis using the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database.
Setting
U.S. hospice programs
Participants
Part D-enrolled Medicare beneficiaries aged 66 and older who were admitted to hospice and died while under hospice care between January 1, 2008, and December 31, 2013 (N = 88,957).
Measurements
We determined the 25 most commonly dispensed medications and the prevalence of at least 1 dispensing through Part D after hospice admission. The prevalence and temporal trends in receipt of opioid analgesics and several preventative medication classes are described.
Results
More than half of individuals admitted to hospice for cancer (53.5%) and noncancer causes (52.9%) received at least 1 medication through Part D after hospice admission. The prevalence of receiving at least 1 Part D medication after admission was greatest in individuals admitted for debility or failure to thrive (63.5%) and dementia (61.5%) and lowest in those admitted for ischemic stroke (35.4%) and renal disease (36.0%). Beta-blockers, angiotensin-converting enzyme inhibitors, proton pump inhibitors, and statins were among the most common preventative drug classes received overall, although prevalence differed according to admission diagnosis. Nearly 1 in 6 individuals received opioids through Part D after admission, with prevalence steadily decreasing over the study period.
Conclusion
Receipt of medications through Medicare Part D after hospice admission is common, particularly for preventative medications, and varies according to admission diagnosis. Further research aimed at better understanding individual-, provider-, and healthcare system–level contributors to nonpalliative medication use in the hospice population is warranted.
from Journal of the American Geriatrics Society http://ift.tt/2H9T0dN
via IFTTT
A Multivariable Prediction Model for Mortality in Individuals Admitted for Heart Failure - American Geriatric Society
Objectives
To derive and validate a 30-day mortality clinical prediction rule for heart failure based on admission data and prior healthcare usage. A secondary objective was to determine the discriminatory function for mortality at 1 and 2 years.
Design
Observational cohort.
Setting
Veterans Affairs inpatient medical centers (n=124).
Participants
The derivation (2010–12; n=36,021) and validation (2013–15; n=30,364) cohorts included randomly selected veterans admitted for HF exacerbation (mean age 71±11; 98% male).
Measurements
The primary outcome was 30-day mortality. Secondary outcomes were 1- and 2-year mortality. Candidate variables were drawn from electronic medical records. Discriminatory function was measured as the area under the receiver operating characteristic curve.
Results
Thirteen risk factors were identified: age, ejection fraction, mean arterial pressure, pulse, brain natriuretic peptide, blood urea nitrogen, sodium, potassium, more than 7 inpatient days in the past year, metastatic disease, and prior palliative care. The model stratified participants into low- (1%), intermediate- (2%), high- (5%), and very high- (15%) mortality risk groups (C-statistic=0.72, 95% confidence interval (CI)=0.71–0.74). These findings were confirmed in the validation cohort (C-statistic=0.70, 95% CI=0.68–0.71). Subgroup analysis of age strata confirmed model discrimination.
Conclusion
This simple prediction rule allows clinicians to risk-stratify individuals on admission for HF using characteristics captured in electronic medical record systems. The identification of high-risk groups allows individuals to be targeted for discussion of goals and treatment.
from Journal of the American Geriatrics Society http://ift.tt/2Fr0DPU
via IFTTT
Using the Hendrich II Inpatient Fall Risk Screen to Predict Outpatient Falls After Emergency Department Visits - American Geriatric Society
Objectives
To evaluate the utility of routinely collected Hendrich II fall scores in predicting returns to the emergency department (ED) for falls within 6 months.
Design
Retrospective electronic record review.
Setting
Academic medical center ED.
Participants
Individuals aged 65 and older seen in the ED from January 1, 2013, through September 30, 2015.
Measurements
We evaluated the utility of routinely collected Hendrich II fall risk scores in predicting ED visits for a fall within 6 months of an all-cause index ED visit.
Results
For in-network patient visits resulting in discharge with a completed Hendrich II score (N = 4,366), the return rate for a fall within 6 months was 8.3%. When applying the score alone to predict revisit for falls among the study population the resultant receiver operating characteristic (ROC) plot had an area under the curve (AUC) of 0.64. In a univariate model, the odds of returning to the ED for a fall in 6 months were 1.23 times as high for every 1-point increase in Hendrich II score (odds ratio (OR)=1.23 (95% confidence interval (CI)=1.19–1.28). When included in a model with other potential confounders or predictors of falls, the Hendrich II score is a significant predictor of a return ED visit for fall (adjusted OR=1.15, 95% CI=1.10–1.20, AUC=0.75).
Conclusion
Routinely collected Hendrich II scores were correlated with outpatient falls, but it is likely that they would have little utility as a stand-alone fall risk screen. When combined with easily extractable covariates, the screen performs much better. These results highlight the potential for secondary use of electronic health record data for risk stratification of individuals in the ED. Using data already routinely collected, individuals at high risk of falls after discharge could be identified for referral without requiring additional screening resources.
from Journal of the American Geriatrics Society http://ift.tt/2H7a5VG
via IFTTT
Monday, March 5, 2018
IDLife, LLC Issues Allergy Alert on Various Undeclared Allergens in its Bars - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Fow3qh
via IFTTT
Kodiak Cakes Issues Allergy Alert on Undeclared Milk in Kodiak Cakes Blueberry Chia Energy Waffles 10.72 oz. Product UPC code is 7 05599 01215 0. - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2Fg1aEW
via IFTTT
Hospira Issues a Voluntary Nationwide Recall for Hydromorphone HCL Injection, USP CII Due to The Potential for Empty or Cracked Glass Vials - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2oTLZ9t
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s commitment to modernizing food and nutrition programs - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2Fsb7hZ
via IFTTT
Friday, March 2, 2018
Steve’s Real Food Voluntarily Recalls Raw Frozen Dog Food Turkey Canine Recipe Due to Possible Salmonella Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2tcq9ng
via IFTTT
Predicting Potential Adverse Events During a Skilled Nursing Facility Stay: A Skilled Nursing Facility Prognosis Score - American Geriatric Society
Objectives
To derive a risk prediction score for potential adverse outcomes in older adults transitioning to a skilled nursing facility (SNF) from the hospital.
Design
Retrospective analysis.
Setting
Medicare Current Beneficiary Survey (2003–11).
Participants
Previously community-dwelling Medicare beneficiaries who were hospitalized and discharged to SNF for postacute care (N=2,043).
Measurements
Risk factors included demographic characteristics, comorbidities, health status, hospital length of stay, prior SNF stays, SNF size and ownership, treatments received, physical function, and active signs or symptoms at time of SNF admission. The primary outcome was a composite of undesirable outcomes from the patient perspective, including hospital readmission during the SNF stay, long SNF stay (≥100 days), and death during the SNF stay.
Results
Of the 2,043 previously community-dwelling beneficiaries hospitalized and discharged to a SNF for post-acute care, 589 (28.8%) experienced one of the three outcomes, with readmission (19.4%) most common, followed by mortality (10.5%) and long SNF stay (3.5%). A risk score including 5 factors (Barthel Index, Charlson-Deyo comorbidity score, hospital length of stay, heart failure diagnosis, presence of an indwelling catheter) demonstrated very good discrimination (C-statistic=0.75), accuracy (Brier score=0.17), and calibration for observed and expected events.
Conclusion
Older adults frequently experience potentially adverse outcomes in transitions to a SNF from the hospital; this novel score could be used to better match resources with patient risk.
from Journal of the American Geriatrics Society http://ift.tt/2GYT4Nn
via IFTTT
Minimum Data Set Changes in Health, End-Stage Disease and Symptoms and Signs Scale: A Revised Measure to Predict Mortality in Nursing Home Residents - American Geriatric Society
Objectives
To revise the Minimum Data Set (MDS) Changes in Health, End-stage disease and Symptoms and Signs (CHESS) scale, an MDS 2.0-based measure widely used to predict mortality in institutional settings, in response to the release of MDS 3.0.
Design
Development of a predictive scale using observational data from the MDS and Medicare Master Beneficiary Summary File.
Setting
All Centers for Medicare and Medicaid Services (CMS)-certified nursing homes in the United States.
Participants
Development cohort of 1.3 million Medicare beneficiaries newly admitted to a CMS-certified nursing home during 2012. Primary validation cohort of 1.2 million Medicare recipients who were newly admitted to a CMS-certified nursing home during 2013.
Measurements
Items from the MDS 3.0 assessments identified as likely to predict mortality. Death information was obtained from the Medicare Master Beneficiary Summary File.
Results
MDS-CHESS 3.0 scores ranges from 0 (most stable) to 5 (least stable). Ninety-two percent of the primary validation sample with a CHESS scale score of 5 and 15% with a CHESS scale of 0 died within 1 year. The risk of dying was 1.63 times as great (95% CI=1.628–1.638) for each unit increase in CHESS scale score. The MDS-CHESS 3.0 is also strongly related to hospitalization within 30 days and successful discharge to the community. The scale predicted death in long-stay residents at 30 days (C=0.759, 95% confidence interval (CI)=0.756–0.761), 60 days (C=0.716, 95% CI=0.714–0.718) and 1 year (C=0.655, 95% CI=0.654–0.657).
Conclusion
The MDS-CHESS 3.0 predicts mortality in newly admitted and long-stay nursing home populations. The additional relationship to hospitalizations and successful discharges to community increases the utility of this scale as a potential risk adjustment tool.
from Journal of the American Geriatrics Society http://ift.tt/2FjeDva
via IFTTT
Rational Suicide in Elderly Adults: A Clinician's Perspective - American Geriatric Society
Geriatricians are increasingly encountering older adults expressing suicidal wishes in the absence of overt mental illness. This is expected to grow as life expectancy increases. This article describes the case of an older adult who expressed the wish to end his life in the absence of a diagnosable mental illness. Although he had chronic medical illnesses, he was not terminally ill. The complex subject of rational suicide in elderly adults is approached from a clinician's perspective. Issues of ageism, gerontophobia, and changing perspectives on death are highlighted. The experience of being a Baby Boomer and its influence on rational suicide is reviewed. Finally, clinical topics such as aging, frailty, dependence on younger and healthier individuals, and the older adult's need for a sense of control are explored.
from Journal of the American Geriatrics Society http://ift.tt/2H08JMm
via IFTTT
Social Causes of Rational Suicide in Older Adults - American Geriatric Society
This editorial comments on the article by Meera Balasubramaniam.
from Journal of the American Geriatrics Society http://ift.tt/2Fivgad
via IFTTT
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program - CMS Blog
CMS Blog
March 2, 2018
By Kate Goodrich, MD
Director, CMS Center for Clinical Standards and Quality & CMS Chief Medical Officer
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity:Measure Development for the Quality Payment Program
CMS is pleased to announce a new funding opportunity for the development, improvement, updating, and expansion of quality measures for use in the Quality Payment Program. CMS will be partnering directly with clinicians, patients, and other stakeholders to provide up to $30 million of funding and technical assistance in development of quality measures over three years.
Cooperative agreements provide a unique opportunity for CMS to partner with external entities, such as clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, and health systems, in developing, improving, updating, and expanding quality measures for the Quality Payment Program. By giving external entities needed resources to help guide their measure-development efforts though this funding opportunity, CMS can leverage the unique perspectives and expertise of these external entities, such as clinician and patient perspectives, to advance the Quality Payment Program measure portfolio. The cooperative agreements will allow CMS to collaborate with stakeholders to address essential topics such as: clinician engagement, burden minimization, consumer-informed decisions, critical measure gaps, quality measure alignment, consumer-informed decisions, clinician engagement, and efficient data collection that minimizes health care provider burden.
The priority measures developed, improved, updated or expanded under the cooperative agreements will be aligned with the CMS Quality Measure Development Plan. The CMS Quality Measure Development Plan provides a strategy for filling clinician and specialty area measure gaps and for recommendations to close these gaps in order to support the Quality Payment Program, and identifies the following initial priority areas for measure development: Clinical Care, Safety, Care Coordination, Patient and Caregiver Experience, Population Health and Prevention, and Affordable Care. The gap areas include, but not limited to: Orthopedic Surgery, Pathology, Radiology, Mental Health and substance use conditions, Oncology, Palliative Care, and Emergency Medicine.
More broadly than the CMS Quality Measure Development Plan, which is specific for the Quality Payment Program, CMS measures work is guided by the Meaningful Measurement framework which identifies the highest priorities for quality measurement and improvement. The Meaningful Measure Areas serve as the connectors between CMS goals under development and individual measures/initiatives that demonstrate how high quality outcomes for our Medicare, Medicaid, and CHIP beneficiaries are being achieved. They are concrete quality topics which reflect core issues that are most vital to high quality care and better patient outcomes.
Through these cooperative agreements, CMS aims to provide the necessary support to help external entities expand the Quality Payment Program quality measure portfolio with a focus on clinical and patient perspectives and minimizing burden for clinicians. Focusing on patient perspectives will ensure measures focus on what is important to patients and drive the improvement of patient outcomes. To accomplish this, the cooperative agreements prioritize the development of: outcome measures, including patient reported outcome and functional status measures; patient experience measures; care coordination measures; and measures of appropriate use of services, including measures of overuse.
For more information, search for the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program on Grants.gov or visit our website, https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/MACRA-MIPS-and-APMs/MACRA-MIPS-and-APMs.html.
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
from The CMS Blog http://ift.tt/2oJkgs2
via IFTTT
Blue Ridge Beef Recalls Kitten Grind Raw Pet Food Lot#GA1102 Because of Possible Contamination - FDA Safety Alerts & Drug Recalls
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2FkHfnS
via IFTTT
FDA warns of fraudulent and unapproved flu products - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2F83kXj
via IFTTT
Thursday, March 1, 2018
FDA alerts health care professionals and patients not to use compounded drugs from Cantrell Drug Company; agency seeks action to stop production and distribution - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2HXaU4S
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods - FDA Press Releases
from Food and Drug Administration--Press Releases http://ift.tt/2FbWu2e
via IFTTT